216 related articles for article (PubMed ID: 11059878)
1. Successful treatment of hepatitis B virus associated polyarteritis nodosa with a combination of prednisolone, alpha-interferon and lamivudine.
Erhardt A; Sagir A; Guillevin L; Neuen-Jacob E; Häussinger D
J Hepatol; 2000 Oct; 33(4):677-83. PubMed ID: 11059878
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B-related polyarteritis nodosa with famciclovir and interferon alfa-2b.
Kruger M; Böker KH; Zeidler H; Manns MP
J Hepatol; 1997 Apr; 26(4):935-9. PubMed ID: 9126810
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery.
Lau CF; Hui PK; Chan WM; Fung TT; Tung YM; Loo CK; Yip WC; Lam KM
Eur J Gastroenterol Hepatol; 2002 May; 14(5):563-6. PubMed ID: 11984157
[TBL] [Abstract][Full Text] [Related]
4. Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients.
Guillevin L; Lhote F; Leon A; Fauvelle F; Vivitski L; Trepo C
J Rheumatol; 1993 Feb; 20(2):289-98. PubMed ID: 8097249
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of polyarteritis nodosa related to hepatitis B virus with a combination of lamivudine and interferon alpha.
Wicki J; Olivieri J; Pizzolato G; Sarasin F; Guillevin L; Dayer JM; Chizzolini C
Rheumatology (Oxford); 1999 Feb; 38(2):183-5. PubMed ID: 10342635
[No Abstract] [Full Text] [Related]
6. HBV-related cutaneous periarteritis nodosa in a patient 16 years after renal transplantation: efficacy of lamivudine.
Bedani PL; Bergami M; Cavazzini PL; Strumia R; Morelli MC; Stabellini G; Gilli P
J Nephrol; 2001; 14(5):428-30. PubMed ID: 11730280
[TBL] [Abstract][Full Text] [Related]
7. Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.
Janssen HL; van Zonneveld M; van Nunen AB; Niesters HG; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2004 Aug; 16(8):801-7. PubMed ID: 15256984
[TBL] [Abstract][Full Text] [Related]
8. Peginterferon-α2a combined with response-guided short-term lamivudine improves response rate in hepatitis B e antigen-positive hepatitis B patients: a pilot study.
Huang Z; Deng H; Zhao Q; Zheng Y; Peng L; Lin C; Zhao Z; Gao Z
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1165-9. PubMed ID: 23571612
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B-related polyarteritis nodosa presenting necrotizing vasculitis in the hepatobiliary system successfully treated with lamivudine, plasmapheresis and glucocorticoid.
Takeshita S; Nakamura H; Kawakami A; Fukushima T; Gotoh T; Ichikawa T; Tsujino A; Ida H; Toriyama K; Hayashi T; Eguchi K
Intern Med; 2006; 45(3):145-9. PubMed ID: 16508228
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B associated polyarteriitis nodosa with cerebral vasculitis].
Kohlhaas K; Brechmann T; Vorgerd M
Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1748-52. PubMed ID: 17713883
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
[TBL] [Abstract][Full Text] [Related]
12. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
[TBL] [Abstract][Full Text] [Related]
13. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
14. Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.
Cao ZH; Ma LN; Zhang HW; Liu YL; Chen XY
J Dig Dis; 2013 Aug; 14(8):446-50. PubMed ID: 23615131
[TBL] [Abstract][Full Text] [Related]
15. Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids.
Deléaval P; Stadler P; Descombes E; Hecker E; Schrago G; Chizzolini C; Nicole A; Pugin P; Regamey C
Clin Rheumatol; 2001; 20(4):290-2. PubMed ID: 11529642
[TBL] [Abstract][Full Text] [Related]
16. [Polyarteritis nodosa and hepatitis B infection treated with lamivudine].
Münster T; Weis NM; Krogsgaard K
Ugeskr Laeger; 2002 Jan; 164(3):342-3. PubMed ID: 11816334
[TBL] [Abstract][Full Text] [Related]
17. [Polyarteritis nodosa related to hepatitis b virus infection].
Demolin G; Delwaide J; Van Severen M; Demolin H; Cornet G; Belaiche J
Rev Med Liege; 1999 Dec; 54(12):921-4. PubMed ID: 10686797
[TBL] [Abstract][Full Text] [Related]
18. [Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B].
Chen CX; Liu B; Ma Y; Zhou YJ; Pan XN; Zhen RD; Wang QC; Wang MR; He CL; Fu QC; Chen CW
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):505-8. PubMed ID: 19912684
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
[TBL] [Abstract][Full Text] [Related]
20. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
